Our study demonstrates that both CIMT and plaque height are independently predictive of significant CAD and at the present time, a combination of both CIMT measurement and an evaluation of plaque burden may be a potential tool for CAD screening. CIMT may be useful in estimating early detection of atherosclerosis and in patients who do not have plaque, while plaque height is sensitive in detecting CAD at any age and level of disease (single and multivessel disease). Therefore, carotid ultrasound with plaque quantification may serve as a useful screening tool for ruling out significant CAD in young patients and assessing extent of disease in older patients. The usefulness as a tool in evaluating preangiogram probability of significant CAD in low- to intermediate-risk population has yet to be determined, but has a high potential.
Mais uma evidência da utilidade da medida da espessura das carótidas.
Exame de baixo custo, rápido e indolor.